ARTICLE | Management Tracks
Quan becomes CMO at Nuvig
Plus new CFO at Toragen and Sinclair joins Arvinas as SVP of corporate operations
August 16, 2022 12:29 AM UTC
Joanne Quan became CMO at Nuvig Therapeutics Inc. Quan was CMO at Modis Therapeutics Inc., a rare genetic disease company. Nuvig is developing therapies to restore immune homeostasis and treat chronic autoimmune disease.
Toragen Inc. hired Cheryl Collett as CFO and Richard Lumpkin as director of R&D. The company also appointed Paul Engler to its board. Collett was CFO of Anivive Lifesciences Inc. and VP finance and accounting for Puma Biotechnology Inc. (NASDAQ:PBYI). Lumpkin was a senior director at Global Blood Therapeutics Inc. (NASDAQ:GBT). Toragen is developing therapies for cancers caused by human papillomavirus...